Information  X 
Enter a valid email address

Tissue Regenix Grp PLC Ord0.1P (TRX)

Related News

12-Oct-2015 07:45 AM

Tissue Regenix widens H1 pretax loss

Tissue Regenix has widened its H1 pretax loss to £4.1m, from a loss of £3.7m. Revenue was £252,000, from £8000. Most of the losses were linked to administrative expenses. Story provided by StockMarketWire.com...
12-Jun-2015 01:02 PM

Tissue Regenix resolutions passed at AGM

Tissue Regenix Group has confirmed that all resolutions proposed at the annual general meeting today were passed. At 1:02pm: (LON:TRX) Tissue Regenix Group PLC share price was -0.25p at 18.5p Story provided by StockMarketWire.com...
11-May-2015 10:58 AM

Tissue Regenix has further success in US

Tissue Regenix Group (AIM:TRX), the regenerative medical devices company, has secured approval for reimbursement on its DermaPure�® product from CGS Medicare. CGS covers the states of Ohio and Kentucky and adds a further 1.9m Medicare beneficiaries w
11-May-2015 07:26 AM

TRX widens FY pretax loss

Tissue Regenix has widened its FY pretax loss to £8.2m, from £6.3m. Its operating loss was £8.5m, from £6.6m. CEO Antony Odell commented: "The year ended 31 January 2015 was a year of real progress for Tissue Regenix. We are delighted, not only
26-Feb-2015 11:03 AM

Alison Fielding leaves Tissue Regenix

Tissue Regenix Group (AIM:TRX), the international regenerative medical devices company, has announced that Dr Alison Fielding has stepped down as a non-executive director with immediate effect. A search for a new independent non-executive director is und
27-Jun-2014 03:11 PM

Tissue Regenix AGM resolutions pass

Tissue Regenix Group (LON:TRX), the regenerative medical devices company, announces that, at the Group's AGM held earlier today, all resolutions were duly proposed to shareholders and passed. At 3:11pm: (LON:TRX) Tissue Regenix share price was -0.7
19-May-2014 10:26 AM

Tissue Regenix gives notice of AGM

Tissue Regenix Group (LON:TRX), the regenerative medical devices company, announces its AGM will be held at DLA Piper UK LLP, Princes Exchange, Princes Square, Leeds LS1 4BY on 27 June 2014 at 10am. At 10:26am: (LON:TRX) Tissue Regenix share price was +
19-May-2014 08:26 AM

Tissue Regenix FY pretax loss widens

Tissue Regenix booked a FY pretax loss of £6.3m, from a loss of £3.9m. Operating income was £6000, from £49,000. "This year we have made significant progress in taking our animal-based development pipeline in woundcare and orthopaedic products t
16-May-2014 01:08 PM

Tissue Regenix adds US patent to portfolio

Tissue Regenix Group, the regenerative medical devices company, has received a formal notice of allowance for a US patent covering the use of its dCELL technology in creating tissue implants for bladder repair. The group has exclusive access to a rang
08-Oct-2013 07:35 AM

Tissue Regenix widens H1 pretax loss to £2.3m

Tissue Regenix widened its H1 pretax loss to £2.3m, from a loss of £1.8m. Operating income was £3000, from £2000. Most of the losses could be attributed to administrative expenses. "We have continued to make good progress on the execution of our
17-Jul-2013 08:05 AM

Tissue Regenix names Steven Couldwell as director

Tissue Regenix has appointed Steven Couldwell as a non-executive director. At 8:05am: (LON:TRX) Torex Retail share price was 0p at 8.75p Story provided by StockMarketWire.com...
10-Jul-2013 07:54 AM

Tissue Regenix names Randeep Singh Grewel director

Tissue Regenix Group has appointed Randeep Singh Grewal as a non-executive director. Story provided by StockMarketWire.com...
18-Jun-2013 07:39 AM

Tissue Regenix advances US commercialisation strategy

Tissue Regenix, the British regenerative medical device company, has signed a processing partnership with Community Tissue Services in the United States. Community Tissue Services is one of the largest tissue banks in the United States, distributing over
14-Jun-2013 01:29 PM

Tissue Regenix dCELL to be presented at heart valve congress

Tissue Regenix research partner Professor Francisco da Costa will present his decellularised 'dCELL' heart valve findings at the 7th Biennial Congress of the Society for Heart Valve Disease & Heart Valve Society of America. The congress is bein
14-Jun-2013 01:04 PM

Tissue Regenix resolutions passed at AGM

Tissue Regenix has confirmed that all resolutions proposed at the annual general meeting were duly passed. At 1:04pm: (LON:TRX) Torex Retail share price was -0.13p at 8.75p Story provided by StockMarketWire.com...
13-May-2013 07:35 AM

Tissue Regenix FY pretax loss widens to £3.9m

Tissue Regenix's full-year pretax loss widened to £3.9 million, from £2.9 million, which reflected the company's ongoing investment in its dCell product offering. It booked operating income of £49,000, from £109,000 a year earlier. During
11-Mar-2013 07:07 AM

Tissue Regenix's Alex Stevenson steps down as director

Story provided by StockMarketWire.com...
11-Feb-2013 03:15 PM

Bretherton steps down from Tissue Regenix board

Tissue Regenix Group non-executive director Mike Bretherton has stepped down from the board. Executive chairman John Samuel said: "I would like to thank Mike for his help and support at Tissue Regenix where he served as CFO after the reverse in 2010
04-Oct-2012 09:37 AM

Operating loss increases as Tissue Regenix ups R&D spend

Tissue Regenix reports that the planned increased investment in multiple development programmes and headcount resulted in an increased operating loss of £2,085k (H1 2011: £1,358k)for the half year. Net cash at the end of the period was £26,106k (H1 20
07-Sep-2012 09:59 AM

Tissue Regenix vascular patch safe and effective

The two year clinical study to evaluate the safety and performance of Tissue Regenix Group's dCELL vascular patch supports the conclusion that it is a safe and effective device when used in vascular surgery. The group of patients was typical of thos
02-Aug-2012 02:37 PM

Tissue Regenix strengthens cardiac team

Tissue Regenix Group has appointed Andrea Rausch as business development manager in its cardiac team. The appointment follows the company's successful £25m fundraising in December, which is enabling Tissue Regenix to continue its planned expansio
25-May-2012 07:35 AM

TRX and NHSBT extend agreement

Tissue Regenix has announces the expansion of its development agreement with existing partner NHS Blood and Transplant (NHSBT). The new agreement will extend the scope of the clinical development activities for Tissue Regenix's decellularised human
10-May-2012 08:05 AM

Increased losses for Tissue Regenix

Tissue Regenix reveals that increased expenditure on product programmes resulted in an increased loss after tax of £2.7m (2011: £1.7m, excluding deemed cost of reverse acquisition of £3.7m) The company revealed that £25.0m was raised (before expenses
16-Apr-2012 03:27 PM

Tissue Regenix schedules FY results

Tissue Regenix will announce its preliminary results for the year to the end of January on 10 May. At 3:27pm: (LON:TRX) Torex Retail share price was 0p at 13.25p Story provided by StockMarketWire.com...
25-Nov-2011 02:44 PM

Tissue Regenix congratulates university partner on Royal Seal

Regenerative medical device company Tissue Regenix has congratulated its university partner on receiving Royal Seal of Approval, the highest accolade possible for an academic institution. The Royal Seal was received by The Institute of Medical and Bi

a d v e r t i s e m e n t